Filing Details
- Accession Number:
- 0001567619-19-021911
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-19 20:15:59
- Reporting Period:
- 2019-11-16
- Accepted Time:
- 2019-11-19 20:15:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1433714 | Castlight Health Inc. | CSLT | Services-Computer Processing & Data Preparation (7374) | 261989091 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1717376 | Eric M.p. Chan | C/O Castlight Health, Inc. 150 Spear St., Suite 400 San Francisco CA 94105 | Chief Accounting Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Class B Common Stock | Acquisiton | 2019-11-16 | 4,688 | $0.00 | 33,702 | No | 4 | M | Direct | |
| Class B Common Stock | Acquisiton | 2019-11-16 | 1,563 | $0.00 | 35,265 | No | 4 | M | Direct | |
| Class B Common Stock | Acquisiton | 2019-11-16 | 1,875 | $0.00 | 37,140 | No | 4 | M | Direct | |
| Class B Common Stock | Disposition | 2019-11-18 | 2,980 | $1.34 | 34,160 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Class B Common Stock | Restricted Stock Units (RSU) | Disposition | 2019-11-16 | 4,688 | $0.00 | 4,688 | $0.00 |
| Class B Common Stock | Restricted Stock Units (RSU) | Disposition | 2019-11-16 | 1,563 | $0.00 | 1,563 | $0.00 |
| Class B Common Stock | Restricted Stock Units (RSU) | Disposition | 2019-11-16 | 1,875 | $0.00 | 1,875 | $0.00 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 37,500 | No | 4 | M | Direct | ||
| 14,059 | No | 4 | M | Direct | ||
| 24,375 | No | 4 | M | Direct |
Footnotes
- Represents the aggregate number of shares sold by the Reporting Person to cover taxes and fees due upon the release and settlement of the RSUs. The Reporting Person did not sell or otherwise dispose of any of the shares reported on this Form 4 for any reason other than to cover required taxes and fees.
- The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.28 to $1.42 per share, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- Each restricted stock unit ("RSU") represents a contingent right to receive 1 share of the Issuer's Class B common stock upon settlement for no consideration.
- 25% of the RSUs vested on November 16, 2018 and the remainder will vest quarterly over three years thereafter in equal installments. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.
- The RSUs vest in equal quarterly installments over four years, beginning on May 16, 2018. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.
- The RSUs vest in equal quarterly installments over four years, beginning on May 16, 2019. Shares of the Issuer's Class B common stock will be delivered to the Reporting Person following vesting, at which time shares will be sold by the Reporting Person to cover any tax withholding obligations.
Billionaire Hedge Funds
